ST. LOUIS, March 22, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective . Centene's Executive Immersion Program is a two-year accelerated program designed to cultivate future leaders through developing high-potential candidates by giving them in-depth experiences across different parts of the business through a clinical, IT, or business track. He will be responsible for Centene's health plans, all lines of business and core operations.. "The healthcare landscape is rapidly changing, and Centene's mission to transform the health of our communities one member at a time has never been more relevant. Get the latest business insights from Dun & Bradstreet. "Additionally, we are excited to welcome two new leaders to our senior management team. Centene Corporation Leaders Founders Executives. U.S. Air Force General Lori J. Robinson is one of the newly elected board of directors members. and Terms and Its operations are primarily divided into two: Managed Care and Specialty Services. The business used to operate in the basement of Family Hospital in Milwaukee. Our specialty companies provide a variety of products and services to deliver integrated healthcare to our members and other organizations. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to:our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively;uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully;restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. Ms. London was part of the team that launched Accretive Health's Quality & Total . Neidorff, who passed away in April, had been Centenes CEO since 1996. Ms. London previously served as Vice President of Client Services & Operations with Humedica, a venture-backed healthcare data and analytics company acquired by Optum in 2013. Centene CEO Shakes Up Management Team. Terms & Conditions. Mar 01, 2021, 07:00 ET. I'm thrilled to be part of this management team, and I firmly believe in the potential of this Company to continue its remarkable history of accomplishment within the healthcare industry.". Opinions expressed by Forbes Contributors are their own. . I write about healthcare business and policy, Centene shuffled its senior management ranks, Wednesday, Dec. 14, 2022, elevating Ken Fasola to become president of the health insurer, reporting to chief executive officer Sarah London. Sarah London is the chief executive officer of Centene Corporation. Dallas will continue to serve on the board and is eligible for reelection next year. CENTOGENE engages in diagnosis and research around rare diseases transforming real-world clinical, genetic, and multiomic data to diagnose, understand, and treat rare diseases. Forward-Looking Statements Centene hourly pay ranges from approximately $18 per hour for a Call Center Representative to $103 per hour for a Management. {{ userNotificationState.getAlertCount('bell') }}. Mr. LeClaire became Centene's CIO on Dec. 5. Centene Corporation Leaders, Founders, and Executives Team. Our local approach allows us to help members access high-quality, culturally sensitive All proxy statements are public filings made available to the general public by the SEC. Sort by. Brian LeClaire. FILTER RATINGS BY. The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. "Brent, Sarah, Shannon and Bob have been integral to our leadership team and, with their new roles, will help us further our commitment to transforming our healthcare model to meet the evolving needs of our members, providers, customers and shareholders.". Executive Vice President of External Affairs. FORTUNE magazine continuously ranks us as one of Americas fastest-growing companies. ST. LOUIS, March 1, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced four executive leadership appointments to support the company's continued growth . Fasola, who had run Magellan Health before Centene bought the company earlier this year, replaces Brent Layton who joined Centene in 2006 and will become Senior Advisor to the CEO, as he begins his transition towards retirement, Centenes statement said. Your innovative thinking and skills can help shape the future of healthcare for our more than 26 million members. Centene is a diversified, national organization offering competitive benefits . Centene is followed by 132 members. Ms. Bagley has been with Centene since 2003 and has performed different job positions. You could be the one who changes everything for our 26 million members as a clinical professional on our Medical Management/Health Services team. "Centene remains focused on innovation, growth, and agility and these leadership enhancements align with key areas of growth for the company," saidMr. Neidorff. CENTENE CORP income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Kenneth Burdick is a retired executive vice president of products and markets of Centene Corp and former CEO of WellCare Health Plans, Inc from 2015; until Centene bought it in January 2020. Cookie Policy. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs. During this 12-week program, you'll learn more about Centene and how we're transforming the health of the community, one person at a time. Our commitment to quality improvement has earned us numerous health plan accreditations and program awards. Strip steak $65.95. Centene has served its communities health and special needs for over 30 years through government-sponsored programs. Chris Koster, secretary and general counsel. corporate governance. Health insurer Centene shuffled its senior management ranks, elevating Ken Fasola to become president of the company and promoting two other executives. The charts on this page feature a breakdown of the total annual pay for the top executives at CENTENE CORP as reported in their proxy statements. Search over 700 When typing in this field, a list of search results will appear and be automatically updated as you type. We ensure quality care while reducing and managing costs, representing significant cost savings and budget predictability over state-paid programs. Her strategic thinking, fresh perspective and diverse experience make her the natural leader to harness the potential of Centene," said James Dallas, Acting Chairman of Centene. removing social barriers to health, and prioritizing responsible The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. The Board and I are confident that she is the right visionary leader to increase value for our shareholders and author the next chapter of Centene's growth. Alice Chen, MD, chief health officer. Thorough reviews have been conducted to assure this data accurately reflects disclosures. You may also find the annual proxy statement by going directly to the company's website. He has overseen the development and implementation of new health plans in 19 states and provided guidance to state governments to develop Medicaid solutions. Ms. London has extensive experience in the industry. Mr. Layton has been with Centene since 2006. You could be the one who changes everything for our 26 million members as a clinical professional on our Medical Management/Health Services team. Staff Directory of Centene Community Ice Center in St Louis. Asher also worked with WellCare where he managed the companys finances for six years. Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Theodore Samuels is a retired president of Capital Guardian Trust Company. 1.4yrs. healthcare services. How experienced are the management team and are they aligned to shareholders interests? View original content:https://www.prnewswire.com/news-releases/centene-appoints-sarah-london-as-chief-executive-officer-301508299.html. Richard A. Gephardt started Gephardt Group in 2005 after serving for 28 years in the U.S. Congress. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions. Mr. Koster joined Centene in 2017 and previously served as Missouri's attorney general. Company profile for Centene Corp. including key executives, insider trading, ownership, revenue and average growth rates. Mr. Asher has served as Centene's CFO since 2021. mesurer votre utilisation de nos sites et applications. TCARE, Inc. is excited to announce that it has expanded its leadership team as the company continues to experience significant growth. Senior executives, directors, and analysts rated enterprises within their own industries and evaluated them on nine criteria, from investment value and quality of management and products, to social responsibly and ability to attract talent. Conditions. She participates in Audit, Compensation, and Technology Committees. She also worked as chief product officer for Optum Analytics, where she is in charge of the strategy and commercialization of the companys integrated data and analytics. Centene is an equal opportunity employer that is committed to diversity, and values the ways in which we are different. Centenefocuses on long-term growth and the development of its people, systems and capabilities so that it can better serve its members, providers, local communities, and government partners. I have been consistently impressed by Sarah's passion to serve our members, who are often the most vulnerable amongst us. This list of important factors is not intended to be exhaustive. She is responsible for overseeing Centenes day-to-day activities, and commanding the overall Centene Corp leadership. London continues to put her stamp on Centenes leadership, elevating Fasola to President from his current position as executive vice president of healthcare enterprises. Compare pay for popular roles and read about the team's work-life balance. Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. Updated Dec 15, 2022. He started working with Centene in 2006. He was Centene's executive vice president of healthcare enterprises before being named president Dec. 14. Nate Moore, former Chief Solutions Officer (CSO) at Centene . Sarah London is the chief executive officer of Centene Corporation. Centene focuses on long-term growth and value creation as well as the development of its people, systems, and capabilities so that it can better serve its members, providers, local communities, and government partners. Together, we're transforming the health of communities, one person at a time. . Celanese is a leader in the development and production of . Centene.com uses cookies. Kansas Department of Corrections Awarded a Contract for Comprehensive Health Services at Kansas Facilities. Senior executives, directors, and analysts rated enterprises within their own industries and evaluated them on nine criteria, from investment value and quality of management and products, to social responsibly and ability to attract talent. We strive to offer services that other Medicaid and Medicare managed care companies do not. Our broad portfolio of approximately 500 product solutions and services includes the following: Our specialty services are a key component of our healthcare strategy and complement our core Managed Care business. Brian Ternan is the CEO of Health Net of California and California Health & Wellness - one of the state's largest Medi-Cal managed care plans. Brent Layton also marked a notable contribution to the government by helping them to do Medicaid reform. healthcare services. Business Journals Centene's profit dipped 10% last year, but says it exceeded guidance. CENTENE CORP annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Leadership as Individual as the People We Serve. CEO. Here's a look at Centene's reshuffled executive leadership team, according to its website: Sarah London, CEO. At Centene, we embrace a multi-business line approach to diversify revenues, control medical costs, improve the quality of care that our members receive, and improve outcomes. Drew Asher has worked as the chief financial officer (CFO) and chief accounting officer since May 2021. Our local approach allows us to help members access high-quality, culturally sensitive Looking for a particular Centene Corporation employee's phone or email? Ms. London previously served as the Company's Senior Vice President of Technology Innovation and Modernization, responsible for enterprise-wide technology strategy and execution with a focus on next-generation products and services. Centene Corporation employs 28,609 employees. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs. . Under his management, Centene won contracts from Delaware. Conditions. Centene Corporation; Facility Overview; Tenants; Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans. Drew Asher, CFO. Centene is a diversified, national organization offering competitive benefits including a fresh perspective on workplace flexibility. Dr. Chen will become the payer's chief health officer on Jan. 1. For example, she created the Employee Inclusion Groups, which aim to improve employee development, retention, and community engagement. Our Environmental, Social, Health, and Governance (ESHG) Strategic Framework expresses our commitments to protect our planet, serve our communities, live our values, and cultivate healthier lives. Corporate citizenship is a key component of our success. Our Managed Care segment provides health plan coverage to individuals through government-subsidized and commercial programs. Chief Information Officer. Si vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit. Here are the Centene Corporation board members. Sarah London is Centenes Vice Chair become becoming a chief executive officer. Other executives include Drew Asher, Chief Financial Officer; Jim Murray, Chief Operating Officer and 17 others. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. Other executives include Christina M. Corley, Chief Commercial and Operating Officer; Sanjay Sood, Senior Vice President & Chief Technology Officer and 30 others. Centene.com uses cookies. 2. Expertise in government-sponsored programs, Localized approach with centralized support infrastructure, Innovative technology and scalable systems, Purchase Order See the full leadership team at Craft. Centene next year will open what Layton called a talent hub for team meetings, training and other events for area employees. Centene Corporation, a Fortune 50 company, is a leading multi-national healthcare enterprise that is committed to helping people live healthier lives. Mr. Trubeck has a wide range of experience in public company governance and organizations with over $1 billion in revenues. For its 2021 fiscal year, CENTENE CORP, listed the following board members on its annual proxy statement to the SEC. Mr. Murray served as Magellan's president and COO. Centene is a diversified, national organization . Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Company, and in her management role was responsible for a portfolio of companies independent of Centene's health plans, designing differentiated platform capabilities, and delivering industry-leading products and services to third-party customers. Centene said in a statement released Wednesday. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: the impact of COVID-19 on global markets, economic conditions, the healthcare industry and our results of operations and the response by governments and other third parties; the risk that regulatory or other approvals required for the Magellan Acquisition may be delayed or not obtained or are obtained subject to conditions that are not anticipated that could require the exertion of management's time and our resources or otherwise have an adverse effect on us; the risk that Magellan Health's stockholders do not approve the definitive merger agreement; the possibility that certain conditions to the consummation of the Magellan Acquisition will not be satisfied or completed on a timely basis and accordingly the Magellan Acquisition may not be consummated on a timely basis or at all; uncertainty as to the expected financial performance of the combined company following completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition will not be realized, or will not be realized within the applicable expected time periods; the exertion of management's time and our resources, and other expenses incurred and business changes required, in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for the Magellan Acquisition; the risk that unexpected costs will be incurred in connection with the completion and/or integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected; the risk that potential litigation in connection with the Magellan Acquisition may affect the timing or occurrence of the Magellan Acquisition or result in significant costs of defense, indemnification and liability; a downgrade of the credit rating of our indebtedness, which could give rise to an obligation to redeem existing indebtedness; the possibility that competing offers will be made to acquire Magellan Health; the inability to retain key personnel; disruption from the announcement, pendency and/or completion and/or integration of the Magellan Acquisition or the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act (ACA) and the Health Care and Education Affordability Reconciliation Act, collectively referred to as the ACA and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions, including the ultimate outcome in "Texas v. United States of America" regarding the constitutionality of the ACA; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of pending or future legal and regulatory proceedings or government investigations; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the possibility that the expected synergies and value creation from acquired businesses, including businesses we may acquire in the future, will not be realized, or will not be realized within the expected time period; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; disruption caused by significant completed and pending acquisitions making it more difficult to maintain business and operational relationships; the risk that unexpected costs will be incurred in connection with the completion and/or integration of acquisition transactions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully; restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations; and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission.